Collections
Indiana Code
Title 12
15
Chapter 35
IC 12-15-35
Drug Utilization Review
Learn More
Log In
Sign Up
1
"Appropriate and medically necessary" defined
2
"Board" defined
3
"Compendia" defined
4
"Counseling" defined
4.5
"Covered outpatient drug" defined
5
"Criteria" defined
6
"Drug-disease contraindication" defined
7
"Drug-drug interaction" defined
8
"Drug utilization review" or "DUR" defined
9
"Intervention" defined
10
"Overutilization or underutilization" defined
11
"Pharmacist" defined
12
"Physician" defined
13
"Prospective DUR" defined
14
"Retrospective DUR" defined
15
"Standards" defined
16
"SURS" defined
17
"Therapeutic appropriateness" defined
17.5
"Therapeutic classification" or "therapeutic category" defined
18
"Therapeutic duplication" defined
18.5
Application of chapter
18.7
Formulary requirements
19
Drug utilization review board; establishment
20
Membership of board
20.1
Conflicts of interest
20.5
Therapeutics committee established; members; limitations; terms; votes; meetings
21
Board; appointment; term
22
Qualifications of board members
23
Physician appointments; geographic balance
24
Reappointment of members
25
Chairman; compensation; expenses
26
Additional staff
27
Retrospective and prospective DUR program responsibility
28
Duties of board; preferred drug list
28.5
Therapeutics committee duties
28.7
Submitting initial preferred drug list; limitations on restrictions; advance notice to providers; implementation; prior authorization limitation; rules
29
Quorum; majority vote on DUR criteria and standards for prescribing
30
Local practices; monitoring
31
Intervention; approval; requisites
32
Repealed
32.1
Annual report contents
33
Repealed
34
Confidential identifying information; release of cumulative nonidentifying information
35
Prior approval program for outpatient drugs; standards
36
Advisory committees
37
Medicaid state plan; inclusion of retrospective and prospective DUR program
38
DUR program guidelines and procedures
39
Retrospective DUR requisites
40
Prospective DUR requisites
41
Board activities under IC 34-30-15
42
Meetings
43
Confidentiality; pharmacist data and information
43.5
Prohibiting the release of proprietary or confidential information obtained under certain circumstances
44
Confidentiality; violations; penalty
45
Outpatient drug formulary; requirements
46
Review of proposed formulary
47
Review of changes to formulary
48
Board review of managed care organization prescription drug program
49
Information provided by office
50
Maximum allowable cost schedule for drugs; pharmacy participation in Medicaid program
51
Advisory committee; duties; report